BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22407308)

  • 1. Juvenile toxicity: are we asking the right questions?
    Downes N
    Toxicol Pathol; 2012 Jul; 40(5):830-7. PubMed ID: 22407308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluations of organ system development in juvenile toxicology testing.
    Robinson K
    Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real life juvenile toxicity case studies: the good, the bad and the ugly.
    De Schaepdrijver L; Rouan MC; Raoof A; Bailey GP; De Zwart L; Monbaliu J; Coogan TP; Lammens L; Coussement W
    Reprod Toxicol; 2008 Sep; 26(1):54-5. PubMed ID: 18514481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling.
    Tassinari MS; Benson K; Elayan I; Espandiari P; Davis-Bruno K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):261-5. PubMed ID: 21594977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of juvenile animal studies: a Japanese industry perspective.
    Shimomura K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):266-8. PubMed ID: 21594974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned from pre-clinical juvenile toxicity studies?
    Bailey GP; Mariën D
    Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of juvenile animal studies.
    Leconte I; Bailey G; Davis-Bruno K; Hew KW; Kim J; Silva Lima B; Liminga U; Moffit J; De Schaepdrijver L; Schmitt G; Tassinari M; Thompson K; Hurtt M
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):292-303. PubMed ID: 22623020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Points to Consider in Designing and Conducting Juvenile Toxicology Studies.
    Kim NN; Parker RM; Weinbauer GF; Remick AK; Steinbach T
    Int J Toxicol; 2017; 36(4):325-339. PubMed ID: 28466670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of juvenile animal studies "What have we learned from preclinical juvenile toxicity studies? II".
    Bailey GP; Mariën D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):273-91. PubMed ID: 22623019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
    Carleer J; Karres J
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of juvenile toxicity.
    Barrow PC; Barbellion S; Stadler J
    Methods Mol Biol; 2011; 691():17-35. PubMed ID: 20972745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of juvenile animal studies: a pediatric clinical perspective.
    Rose K
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):252-3. PubMed ID: 21594978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of the minipig as an animal model in regulatory toxicology.
    Bode G; Clausing P; Gervais F; Loegsted J; Luft J; Nogues V; Sims J;
    J Pharmacol Toxicol Methods; 2010; 62(3):196-220. PubMed ID: 20685310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory forum opinion piece*: reversibility groups: the "hows" and "how-nots".
    Ochoa R
    Toxicol Pathol; 2013; 41(3):552-3. PubMed ID: 22821368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving toxicity screening and drug development by using genetically defined strains.
    Festing MF
    Methods Mol Biol; 2010; 602():1-21. PubMed ID: 20012389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The minipig in toxicology.
    Svendsen O
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and pathology considerations for the design of juvenile animal studies.
    Seely JC
    Lab Anim (NY); 2008 May; 37(5):206-9. PubMed ID: 18431394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.